No abstract available
MeSH terms
-
Biological Products / economics*
-
Biological Products / therapeutic use
-
Cost Savings
-
Diffusion of Innovation
-
Drug Approval / economics*
-
Drug Approval / legislation & jurisprudence
-
Drugs, Generic / economics*
-
Drugs, Generic / standards
-
Economic Competition
-
European Union
-
Health Care Reform
-
Health Policy*
-
Humans
-
Legislation, Drug
-
Medicaid
-
Medicare
-
Patents as Topic / legislation & jurisprudence
-
Reimbursement Mechanisms / economics*
-
Reimbursement Mechanisms / legislation & jurisprudence
-
Therapeutic Equivalency
-
United States
-
United States Food and Drug Administration
Substances
-
Biological Products
-
Drugs, Generic